Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

Stock Information for Psychemedics Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Psychemedics Corporation

Psychemedics Corporation Reports 2023 Financial Results
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
Psychemedics Corporation Reports Third Quarter 2023 Financial Results
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.